- ►annals.org [PDF] SL Hogan, RJ Falk, H Chin, J Cai, CE … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Predictors of treatment resistance and relapse have not been well
described in antineutrophil cytoplasmic antibody (ANCA)–associated
small-vessel vasculitis. Objective: To identify clinical, pathologic, and ... Cited by 85 - Related articles - BL Direct - All 4 versions
K De Groot, N Rasmussen, PA Bacon, JWC … - Arthritis and rheumatism, 2005 - vasculitis.nl Objective. Standard therapy for antineutrophil cytoplasmic antibody–associated
systemic vasculitis (AASV) with cyclophosphamide (CYC) and pred- nisolone is
limited by toxicity. This unblinded, prospec- tive, randomized, controlled ... Cited by 156 - Related articles - View as HTML - BL Direct - All 10 versions
MC Slot, JWC Tervaert, MM Boomsma, CA … - Arthritis & Rheumatism, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 53 - Related articles - BL Direct - All 3 versions
- ►vasculitis.org [PDF] B Hellmich, O Flossmann, WL Gross, P Bacon, … - British Medical Journal, 2006 - ard.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 22 - Related articles - All 2 versions
- ►jrheum.com W Koldingsnes, JC Nossent - Journal of Rheumatology, 2003 - jrheum.org From the Department of Rheumatology, Institute of Clinical Medicine, University
of Tromsø, Tromsø, Norway. Supported by grants from the Norwegian Women's
Public Health Association and the Norwegian Rheumatology Society. W. ... Cited by 35 - Related articles - BL Direct - All 11 versions
R Birck, WH Schmitt, IA Kaelsch, FJ van der … - American Journal of Kidney Diseases, 2006 - Elsevier Background: Antineutrophil cytoplasmic antibodies (ANCAs) are considered by some
investigators to be sensitive markers of disease activity and have been
suggested to predict relapse and guide therapeutic decisions. Studies using ... Cited by 33 - Related articles - All 7 versions
- ►oxfordjournals.org JSF Sanders, MG Huitma, CGM Kallenberg, … - Rheumatology, 2006 - Br Soc Rheumatology Methods. Patients diagnosed with PR3-ANCA-associated vasculitis between 1991 and
2002, with at least 2 yr of follow-up, and treated with cyclophosphamide and
corticosteroids only (1991–1996) or switched to azathioprine after ... Cited by 31 - Related articles - BL Direct - All 5 versions
DJ Schlieben, SM Korbet, RE Kimura, MM … - American Journal of Kidney Diseases, 2005 - Elsevier Despite clinical and experimental data suggesting a direct relationship between
antineutrophil cytoplasmic antibodies (ANCAs) and disease activity in patients
with microscopic polyangiitis (MPA), the causal relationship between ... Cited by 46 - Related articles - All 10 versions
- ►asnjournals.org [PDF] A Allen, C Pusey, G Gaskin - Journal of the American Society of Nephrology, 1998 - Am Soc Nephrol Page 1. J Ani Soc Nephrol 9: 1258-1263, 1998 Outcome of Renal Replacement Therapy
in Antineutrophil Cytoplasmic Antibody-Associated Systemic Vasculitis ... Cited by 55 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org JC Jennette, H Xiao, RJ Falk - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol The reports of a newborn who developed glomerulonephritis and pulmonary
hemorrhage after transplacental transfer of anti-neutrophil cytoplasmic antibody
(ANCA) IgG with specificity for myeloperoxidase (MPO) is compelling ... Cited by 52 - Related articles - BL Direct - All 5 versions
